WELCOME TO THE EARLY SPRING 2022 AMR DETECTOOL NEWSLETTER
Dear Reader,
We are excited to send you the third newsletter of the AMR DetecTool project (2020-2022). Our project is committed to the fight against antimicrobial resistance (AMR) by further developing and testing a rapid detection device.
We are in the last year of the project, and although the COVID-epidemiological situation continues to complicate our work, we make every effort to get everything done.
The highlight of last year was the workshop that we could hold fortunately in person in Barcelona, and those interested could also participate online.
A short summary of our great workshop in Barcelona:
Key presentation of the Barcelona workshop
Jordi Vila (President of the Spanish Society of Infectious Diseases and Clinical Microbiology) on the impact of COVID-19 on the global situation of antimicrobial resistance. – VIDEO
Thierry Naas (Associate Professor in Medical Microbiology) asking and answering the question: Will AMR benefit from the pandemic? Some thought-provoking facts: we now wear a mask, we use hand sanitisers, and our travels are restricted. – VIDEO
Katalin Kamotsay (Head of the Microbiology Department at the South-Pest Central Hospital in Budapest) providing colourful insight into the everyday life of microbiology laboratories and talking about the urgency of a proper rapid diagnosis – as roughly 50% of treatments are not started with well-targeted antibiotics – VIDEO
Stefan Raupach (Chief Business Officer at NG Biotech) o the challenges NGBiotech is facing during the COVID crisis, and how it has been able to contribute to the fight against the epidemic. – VIDEO
Mariana Fernández-Pittol (Clinical microbiologist in the Hospital Clinic of Barcelona) and Veronica Rico (Infectious disease specialist at Hospital Clinic of Barcelona) on the epidemiology of one of the most common bacterial infections and the clinical impact of the use of rapid diagnostic tests in these cases. – VIDEO
Roger Marginet (Chief of AMR products and infectious diseases) and Oriol Cuxart (Biomedical Engineer at IESE Business School, Barcelona) on the situation of antimicrobial resistance testing market in Europe and in low- and middle-income countries. – Roger Marginet’s VIDEO – Oriol Cuxart’s VIDEO
Based on interviews with hospitals participating in clinical trials, Oriol Cuxart presented how to integrate AMRDetecTool into the workflows of hospital laboratories. – VIDEO
All information about the workshop is available here.
AMR is no longer the next pandemic. It is already here with us.
Millions are dying from drug-resistant infections – according to a research published in one of the world’s oldest and best-known general medical journals, The Lancet.
Infections caused by antibiotic-resistant bacteria are among the leading causes of death for people of all ages, finds the most comprehensive global study of antimicrobial resistance yet.
On the basis of predictive statistical models, there were an estimated 4.95 million deaths associated with bacterial AMR in 2019, including 1.27 million deaths attributable to bacterial AMR.
https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(21)02724-0/fulltext
As COVID-19 rages on, the pandemic of antimicrobial resistance (AMR) continues in the shadows. The toll taken by AMR on patients and their families is largely invisible but is reflected in prolonged bacterial infections that extend hospital stays and cause needless deaths.
The true burden of resistance could be greater than that estimated in this study. Modern medicine, including surgeries, chemotherapy, organ transplantations, and other invasive procedures require effective antibiotics.
https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(22)00087-3/fulltext
The mission of the AMR DetecTool project is to fight against antimicrobial resistance
Rapid detection is essential to prescribe patients an effective treatment in time and prevent the spread of antibiotic resistance.
The AMR DetecTool device can detect the most common resistance mechanisms of bacteria directly from the patient’s sample.
Rapid detection allows patients to receive the appropriate antibiotic in a shorter period of time, so the recovery time is also shorter, and the length of hospital stay decreases.
Find out more on the AMR expert website: amrexpert.eu
You can also see us on social media, please look for #AMRDetection
Thank you for staying with us,
Best wishes:
Albert Zoltan Aszalos
Szilvia Farkas
